RESUMO
Maintenance of blood glucose by the liver is normally initiated by extracellular regulatory molecules such as glucagon and vasopressin triggering specific hepatocyte receptors to activate the cAMP or phosphoinositide signal transduction pathways, respectively. We now show that the normal ligand-receptor regulators of blood glucose in the liver can be bypassed using an adenovirus vector expressing the mouse pituitary thyrotropin releasing hormone receptor (TRHR) cDNA ectopically in rat liver in vivo. The ectopically expressed TRHR links to the phosphoinositide pathway, providing a means to regulate liver function with TRH, an extracellular ligand that does not normally affect hepatic function. Administration of TRH to these animals activates the phosphoinositide pathway, resulting in a sustained rise in blood glucose. It should be possible to use this general strategy to modulate the differentiated functions of target organs in a wide variety of pathologic states.
Assuntos
Glicemia/metabolismo , Técnicas de Transferência de Genes , Fígado/fisiologia , Receptores do Hormônio Liberador da Tireotropina/genética , Hormônio Liberador de Tireotropina/fisiologia , Adenoviridae/genética , Animais , Células Cultivadas , Estudos de Viabilidade , Vetores Genéticos , Camundongos , Fosfatidilinositóis/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores do Hormônio Liberador da Tireotropina/biossíntese , Receptores do Hormônio Liberador da Tireotropina/fisiologia , Proteínas Recombinantes de Fusão , Transdução de SinaisRESUMO
The adenovirus major late transcription unit is a well-characterized transcription unit which relies heavily on alternative pre-mRNA processing to generate distinct populations of mRNA during the early and late stages of viral infection. In the early stage of infection, two major late transcription unit mRNA transcripts are generated through use of the first (L1) of five available poly(A) sites (L1 through L5). This contrasts with the late stage of infection when as many as 45 distinct mRNAs are generated, with each of the five poly(A) sites being used. In previous work characterizing elements involved in alternative poly(A) site use, we showed that the L1 poly(A) site is processed less efficiently than the L3 poly(A) site both in vitro and in vivo. Because of the dramatic difference in processing efficiency and the role processing efficiency plays in production of steady-state levels of mRNA, we have identified the sequence elements that account for the differences in L1 and L3 poly(A) site processing efficiency. We have found that the element most likely to be responsible for poly(A) site strength, the GU/U-rich downstream element, plays a minor role in the different processing efficiencies observed for the L1 and L3 poly(A) sites. The sequence element most responsible for inefficient processing of the L1 poly(A) site includes the L1 AAUAAA consensus sequence and those sequences which immediately surround the consensus hexanucleotide. This region of the L1 poly(A) site contributes to an inability to form a stable processing complex with the downstream GU/U-rich element. In contrast to the L1 element, the L3 poly(A) site has a consensus hexanucleotide and surrounding sequences which can form a stable processing complex in cooperation with the downstream GU/U-rich element. The L3 poly(A) site is also aided by the presence of sequences upstream of the hexanucleotide which facilitate processing efficiency. The sequence UUCUUUUU, present in the L3 upstream region, is shown to enhance processing efficiency as well as stable complex formation (shown by increased binding of the 64-kDa cleavage stimulatory factor subunit) and acts as a binding site for heterogeneous nuclear ribonucleoprotein C proteins.
Assuntos
Adenoviridae/genética , DNA Viral/metabolismo , Poli A/metabolismo , Precursores de RNA/metabolismo , RNA Mensageiro/biossíntese , RNA Mensageiro/metabolismo , Adenoviridae/metabolismo , Processamento Alternativo , Sequência de Bases , Quimera , Cloranfenicol O-Acetiltransferase/biossíntese , Sondas de DNA , DNA Viral/genética , Células HeLa , Humanos , Dados de Sequência Molecular , Plasmídeos , Regiões Promotoras Genéticas , Mapeamento por Restrição , Deleção de Sequência , TransfecçãoRESUMO
For the majority of mRNA encoding eukaryotic transcription units, there is little or no knowledge of the elements responsible for transcription termination or how they may interact with RNA polymerase. In this report, we have used recombinant adenovirus reporter vectors to characterize the mouse beta maj globin sequence elements that cause transcription termination. Within the globin 3' termination region, we have identified at least three sequence elements which induce significant levels of transcription termination (> 50%). The smallest functionally active element (64% termination) is 69 bp in length. The natural arrangement of these elements results in a cumulative termination which is greater than 90%. Recognition of the termination elements by RNA polymerase II depends on the presence of a functional poly(A) signal sequence. We demonstrate that efficient transcription termination depends on appropriate spacing between the poly(A) signal sequence and the termination element.
Assuntos
Globinas/genética , RNA Mensageiro/genética , Regiões Terminadoras Genéticas , Animais , Sequência de Bases , Células HeLa , Humanos , Técnicas In Vitro , Camundongos , Dados de Sequência Molecular , Poli A/metabolismo , RNA Polimerase II/metabolismo , Processamento Pós-Transcricional do RNA , Sequências Reguladoras de Ácido Nucleico , Deleção de SequênciaRESUMO
Temporal regulation of poly(A) site choice occurs in an adenovirus recombinant encoding a miniature version of the major late transcription unit with two poly(A) sites, L1 and L3. Using deletion mutagenesis, we have looked directly for cis-acting elements regulating poly(A) site choice in this recombinant. From this work, we draw two main conclusions. First, elements other than the AAUAAA and downstream sequences of the L1 poly(A) site are required for temporal regulation of poly(A) site choice during infection. Second, these regions function in two distinct modes during infection. The two regions enhance selection of the L1 poly(A) site in an additive manner during an early infection, but deletion of either element abolishes the switch in poly(A) site choice during a late infection. This work documents the first example of a regulatory element downstream of a core poly(A) region.
Assuntos
Adenovírus Humanos/genética , Poli A/metabolismo , Processamento Pós-Transcricional do RNA , Sequências Reguladoras de Ácido Nucleico , Transcrição Gênica , Adenovírus Humanos/fisiologia , Linhagem Celular , Humanos , Mutagênese , Transfecção , Replicação Viral/genéticaRESUMO
In several mammalian transcription units, a transcription termination mechanism in which efficient termination is dependent on the presence of an intact 3' RNA processing site has been identified. The mouse beta maj-globin transcription unit is one such example, in which an intact poly(A) site is required for efficient transcription termination. It is now evident that 3' mRNA processing sites are not always processed with the same efficiency. In this study, we characterized several pre-mRNAs as substrates for the 3' mRNA processing reaction of cleavage and polyadenylation. We then determined whether poly(A) sites which vary in processing efficiency support a poly(A) site-dependent termination event. The level of processing efficiency was determined in vitro by assays measuring the efficiency of the pre-mRNA cleavage event and in vivo by the level of poly(A) site-dependent mRNA and gene product expression generated in transient transfection assays. The beta maj globin pre-mRNA is very efficiently processed. This efficient processing correlates with its function in termination assays using recombinant adenovirus termination vectors in nuclear run-on assays. When the beta maj globin poly(A) site was replaced by the L1 poly(A) site of the adenovirus major late transcription unit (Ad-ml), which is a poor processing substrate, termination efficiency decreased dramatically. When the beta maj globin poly(A) site was replaced by the Ad-ml L3 poly(A) site, which is 10- to 20-fold more efficiently processed than the Ad-ml L1 poly(A) site, termination efficiency remained high. Termination is therefore dependent on the yield of the processing event. We then tested chimeric poly(A) sites containing the L3 core AAUAAA but varied downstream GU-rich elements. The change in downstream GU-rich elements affected processing efficiency in a manner which correlated with termination efficiency. These experiments provide evidence that the efficiency of 3' processing complex formation is directly correlated to the efficiency of RNA polymerase II termination at the 3' end of a mammalian transcription unit.
Assuntos
Adenoviridae/genética , Globinas/genética , RNA Polimerase II/metabolismo , Processamento Pós-Transcricional do RNA , RNA Mensageiro/biossíntese , Transcrição Gênica , Proteínas E1A de Adenovirus/genética , Proteínas E1B de Adenovirus/genética , Sequência de Bases , Linhagem Celular , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Genes Virais , Células HeLa , Humanos , Rim , Dados de Sequência Molecular , Poli A/genética , Poli A/metabolismo , RNA/genética , RNA/metabolismo , Precursores de RNA/metabolismo , RNA Mensageiro/genética , Proteínas Recombinantes de Fusão/metabolismo , TransfecçãoRESUMO
Gene expression in complex transcription units can be regulated at virtually every step in the production of mature cytoplasmic mRNA, including transcription initiation, elongation, termination, pre-mRNA processing, nucleus-to-cytoplasm mRNA transport, and alterations in mRNA stability. We have been characterizing alternative poly(A) site usage in the adenovirus major late transcription unit (MLTU) as a model for regulation at the level of pre-mRNA 3'-end processing. The MLTU contains five polyadenylation sites (L1 through L5). The promoter proximal site (L1) functions as the dominant poly(A) site during the early stage of adenovirus infection and in plasmid transfections when multiple poly(A) sites are present at the 3' end of a reporter plasmid. In contrast, stable mRNA processed at all five poly(A) sites is found during the late stage of adenovirus infection, after viral DNA replication has begun. Despite its dominance during early infection, L1 is a comparatively poor substrate for 3'-end RNA processing both in vivo and in vitro. In this study we have investigated the basis for the early L1 dominance. We have found that mRNA containing an unprocessed L1 poly(A) site is compromised in its ability to enter the steady-state pool of stable mRNA. This inhibition, which affects either the nuclear stability or nucleus-to-cytoplasm transport of the pre-mRNA, requires a cis-acting sequence located upstream of the L1 poly(A) site.
Assuntos
Adenovírus Humanos/genética , Genes Virais , RNA Mensageiro/metabolismo , RNA Viral/metabolismo , Adenovírus Humanos/metabolismo , Sequência de Bases , Sítios de Ligação/genética , Linhagem Celular , Regulação Viral da Expressão Gênica , Células HeLa , Humanos , Mutação , Regiões Promotoras Genéticas , Processamento Pós-Transcricional do RNA , RNA Mensageiro/genética , RNA Viral/genética , TransfecçãoRESUMO
To evaluate the contribution of the innate immune component of host defense in clearing the genome of adenovirus (Ad) vectors following in vivo administration, the Ad vectors AdCMV.beta gal (expressing beta-galactosidase) or AdCMV.Null (expressing no gene) were administered intravenously to immunocompetent or immunodeficient mice, and the amount of vector genome was quantified in the liver. Strikingly, 90% of vector DNA was eliminated within 24 hr. There was no increase in vector DNA in other tissues over this period, suggesting that rapid clearance of vector genome resulted from local degradation. After 24 hr, vector elimination was slow, with only 9% of the initial amount of vector genome cleared over the subsequent 3 weeks. Importantly, early phase (0-24 hr) elimination of vector DNA was independent of the transgene and similar in immunocompetent and nude animals. These observations suggest two phases of Ad vector elimination: a previously recognized late, immune-related elimination, and the early, innate immune elimination described in the present study. The early phase of vector loss is, by far, the dominant mechanism, an observation that has implications in developing strategies to maintain persistent expression of the newly transferred gene following in vivo gene therapy.
Assuntos
Adenoviridae/metabolismo , Vetores Genéticos/genética , Imunidade , Animais , Southern Blotting , Sondas de DNA , DNA Viral/metabolismo , Regulação da Expressão Gênica/genética , Técnicas de Transferência de Genes , Vetores Genéticos/metabolismo , Imunidade/imunologia , Fígado/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , beta-Galactosidase/genética , beta-Galactosidase/metabolismoRESUMO
Recombinant, replication-deficient adenovirus (Ad) vectors have been successfully used to transfer and express the normal human cystic fibrosis transmembrane conductance regulator (CFTR) cDNA in vivo in the respiratory epithelium of experimental animals and humans with cystic fibrosis (CF). Since Ad-directed gene expression wanes over time, repeat administration is necessary to achieve an effective treatment for CF. A major hurdle to such a strategy is the possibility that anti-Ad humoral immunity may prevent gene expression in individuals with pre-existing anti-Ad immunity or following repeat administration. One strategy to circumvent such a problem would be alternating the use of Ad vectors belonging to different subgroups. Neutralizing antibodies developed with the administration of one Ad serotype do not cross-react with an Ad belonging to a second serotype in a manner that blocks infection and gene expression. To test this hypothesis, an immunizing dose of wild-type Ad5 (subgroup C), Ad4 (subgroup E), or Ad30 (subgroup D) was administered intratracheally to experimental animals, followed by an intratracheal administration of a replication-deficient subgroup C-derived vector coding for marker genes (chloramphenicol acetyl transferase or beta-galactosidase) or for the normal human CFTR cDNA. As expected, studies with vectors coding for marker genes or for CFTR cDNA demonstrated that airway administration of a vector does not yield efficient gene transfer, if there has been prior recent airway administration of the same Ad subgroup. In contrast, effective expression from the second administration can be achieved with an adenovirus vector belonging to a subgroup different from the first adenovirus administered. These data support the paradigm of alternating Ad vectors derived from different subgroups as strategy to circumvent anti-Ad humoral immunity, thus permitting the use of Ad vectors as a means to treat the respiratory manifestations of CF.
Assuntos
Adenovírus Humanos/imunologia , Técnicas de Transferência de Genes , Vetores Genéticos/imunologia , Adenovírus Humanos/genética , Adenovírus Humanos/isolamento & purificação , Animais , Cloranfenicol O-Acetiltransferase/genética , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Feminino , Expressão Gênica , Vetores Genéticos/genética , Humanos , Pulmão , Masculino , Testes de Neutralização , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , SorotipagemRESUMO
Effective gene transfer and expression following repetitive administration of adenoviral (Ad) vectors in experimental animals is limited by anti-Ad neutralizing antibodies. Knowing that anti-Ad humoral immunity is serotype-specific, we hypothesized that anti-Ad neutralizing immunity could be circumvented using Ad vectors of different serotypes (Ad2, Ad5) within the same subgroup (C) to transfer and express beta-glucuronidase (beta glu) in the lung. Sprague-Dawley rats received an intratracheal administration of either Ad2 beta glu or Ad5 beta glu, and, 14 days later, repeat administration of either the same vector or a vector of a different serotype. Analysis of serum and bronchoalveolar lavage fluid following initial vector administration demonstrated systemic and local serotype-specific neutralizing antibodies. For both the Ad2 and Ad5 vectors, beta glu expression 24 hr following the second administration of the same serotype was < 30% of that of naive animals. In contrast, beta glu expression 24 hr following second administration of a different serotype Ad vector was similar to expression at 24 hr of naive animals receiving a single administration (Ad5 beta glu followed by Ad2 beta glu, as well as Ad2 beta glu followed by Ad5 beta glu; p > 0.2 both comparisons). Although the alternative serotype bypassed anti-Ad neutralizing immunity, persistence of expression was reduced compared to that following administration to naive animals. Compatible with this observation, systemic administration of the same vectors to C57B1/6 mice demonstrated induction of cytotoxic T lymphocytes directed against the beta glu transgene, as well as products of the Ad genome. Interestingly, intratracheal administration of vectors with different serotypes and different transgenes to rats resulted in longer expression (but still not normalized) compared to that achieved with vectors of different serotypes but the same transgene. These observations demonstrate that alternate use of Ad vectors from different serotypes within the same subgroup can circumvent anti-Ad humoral immunity to permit effective gene transfer after repeat administration, although the chronicity of expression is limited, likely by cellular immune process directed against both the transgene and viral gene products expressed by the vector.
Assuntos
Adenoviridae/imunologia , Técnicas de Transferência de Genes , Imunidade/imunologia , Adenoviridae/genética , Animais , Anticorpos/sangue , Anticorpos/farmacologia , Líquido da Lavagem Broncoalveolar/química , Células Cultivadas , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Regulação Viral da Expressão Gênica/genética , Vetores Genéticos/genética , Glucuronidase/genética , Glucuronidase/metabolismo , Pulmão/virologia , Camundongos , Camundongos Endogâmicos , Ratos , Ratos Sprague-Dawley , Sorotipagem , Linfócitos T Citotóxicos/imunologia , Linfócitos T Citotóxicos/metabolismo , Proteínas Virais/imunologia , Proteínas Virais/metabolismoRESUMO
Regulation of adenovirus major late transcription unit (MLTU) mRNA biosynthesis involves poly(A) site selection between five available sites, L1 through L5. The 5' proximal site completely dominates during early infection, whereas all five sites are used during late infection with L3 being favored slightly over the others. Previous studies have shown this early to late poly(A) switch will occur in the absence of MLTU-specific splicing patterns and hinges in large part on the character of the first poly(A) site. We have used in vitro assays to characterize basic features of the L1 and L3 pre-mRNAs which may help define how processing at poly(A) sites is controlled. We have found that L1 is 5-10-fold less efficient than L3 as a substrate for RNA cleavage. A primary difference between the L1 and L3 sites lies in the kinetics of their use, with cleavage at L3 occurring at twice the rate of cleavage at L1. In addition, L1 is 20-fold less effective than L3 in competing for processing factors. To investigate the sequence elements that contribute to poly(A) site efficiency, we have used competition assays in which the competitor RNAs lack upstream or downstream elements.
Assuntos
Proteínas de Ligação a DNA/metabolismo , Poli A/metabolismo , Fatores de Transcrição/metabolismo , Proteínas de Ligação a DNA/genética , Células HeLa , Humanos , Cinética , Plasmídeos , Processamento Pós-Transcricional do RNA , RNA Mensageiro/biossíntese , RNA Mensageiro/metabolismo , Especificidade por Substrato , Fatores de Transcrição/genética , Proteínas ViraisRESUMO
We have investigated the mechanisms involved in the early-to-late RNA-processing switch which regulates the mRNA species generated from the adenovirus major late transcription unit (MLTU). In particular, polyadenylation choice mechanisms were characterized by using a reconstructed adenovirus E1A gene as a site for insertion of MLTU poly(A) regulation signals (L1 and L3). Adenovirus constructs containing the variant poly(A) recognition elements were used to compare E1A poly(A) signal utilization with wild-type MLTU (L1 to L5) utilization. In both early and late stages of infection, either polyadenylation site (L1 or L3) is capable of being utilized when presented as the only operational poly(A) site. In an early infection, a virus which contains multiple elements presented in tandem (L13) uses the first poly(A) site, L1, preferentially (ratio of L1 to L3, 8:1) in both E1A and MLTU loci. Transcription termination is not involved in restricting the utilization of the downstream L3 site. In a late infection, when each of the five MLTU poly(A) sites is used, a switch also occurs for the E1AL13 construct, with utilization of both the L1 and L3 poly(A) sites. The switch from early to late was not the result of altered processing factors in the late infection, as demonstrated by superinfecting the E1AL13 construct into cells which had already entered a late stage of infection. The superinfecting virus gave an L1-only phenotype; therefore, a cis mechanism is involved in adenovirus poly(A) regulation.
Assuntos
Adenoviridae/genética , Genes Reguladores , Genes de Troca , Genes Virais , Poli A/metabolismo , RNA Mensageiro/metabolismo , RNA Viral/metabolismo , Proteínas Precoces de Adenovirus , Genes Sintéticos , Proteínas Oncogênicas Virais/genética , Processamento Pós-Transcricional do RNA , Transcrição GênicaRESUMO
The T cell coreceptor, CD8, enhances T cell-APC interactions. Because soluble CD8alpha homodimers can antagonize CD8 T cell activation in vitro, we asked whether secretion of soluble CD8 would effect cytotoxic T cell responses in vivo. Production of soluble CD8 by a replication-defective adenovirus vector allowed persistent virus expression for up to 5 mo in C57BL/6 mice and protected a second foreign transgene from rapid deletion. Soluble CD8 selectively inhibited CD8 T cell proliferation and IFN-gamma production and could also attenuate peptide-specific CD8 T cell responses in vivo. These finding suggest that gene vector delivery of soluble CD8 may have therapeutic applications.
Assuntos
Adenoviridae/imunologia , Antígenos CD8/fisiologia , Vírus Defeituosos/imunologia , Regulação da Expressão Gênica/imunologia , Linfócitos T Citotóxicos/imunologia , Transgenes/imunologia , Adenoviridae/genética , Adenoviridae/fisiologia , Animais , Antígenos CD8/biossíntese , Antígenos CD8/sangue , Antígenos CD8/genética , Linfócitos T CD8-Positivos/imunologia , Testes Imunológicos de Citotoxicidade , Citotoxicidade Imunológica/imunologia , Vírus Defeituosos/genética , Vírus Defeituosos/fisiologia , Epitopos de Linfócito T/administração & dosagem , Epitopos de Linfócito T/imunologia , Vetores Genéticos/administração & dosagem , Vetores Genéticos/síntese química , Vetores Genéticos/imunologia , Imunossupressores/sangue , Imunossupressores/farmacologia , Injeções Intravenosas , Fígado/citologia , Fígado/imunologia , Ativação Linfocitária/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Ovalbumina/administração & dosagem , Ovalbumina/imunologia , Proteínas Recombinantes de Fusão/biossíntese , Solubilidade , Linfócitos T Citotóxicos/virologia , Replicação Viral/genética , Replicação Viral/imunologiaRESUMO
We have previously reported that antibody secretion by B.22 hybridoma cells can be suppressed in an MHC-restricted manner, by idiotype-specific T cells. It was shown that T cells of both helper and suppressor phenotypes are involved, and that the suppression is mediated by soluble factors. In the present paper, we have characterized the effects of T-cell-mediated suppression at the level of B.22 antibody mRNA expression and stability. Nuclear run-on analysis comparing suppressed and control B.22 cells indicates no change in the transcription rates of heavy and light chains. Northern blot analysis demonstrates that steady-state levels of heavy and light chain mRNAs are also unchanged. Thus, the suppression of antibody secretion by B.22 cells probably occurs at the levels of translation or secretion.
Assuntos
Anticorpos Monoclonais/genética , Hibridomas/fisiologia , Idiótipos de Imunoglobulinas/fisiologia , Linfócitos T Auxiliares-Indutores/fisiologia , Animais , Regulação da Expressão Gênica , Tolerância Imunológica , Cadeias Pesadas de Imunoglobulinas/genética , Cadeias Leves de Imunoglobulina/genética , Camundongos , Camundongos Endogâmicos , RNA Mensageiro/genética , Linfócitos T Reguladores/fisiologia , Transcrição GênicaRESUMO
The innate immune response against replication-defective adenoviruses (Ad) is poorly defined. We and others have previously observed striking differences in the rate at which the Ad vector itself or the virus encoding a variety of transgenes is eliminated in different mouse strains. Here, we report that Ad infection of BALB/ mice is associated with sixfold-higher levels of serum alanine aminotransferase and that Ad transgenes induce two- to threefold-higher levels of intrahepatic NK cells and NK activity compared to C57BL/6 mice. The increase in NK activation in BALB/c mice was associated with approximately 4-fold higher level of mRNA expression of a newly described NKG2 receptor activator, H-60, as well as increased expression of interleukin-12 and gamma interferon mRNAs in BALB/c mice compared to C57BL/6 mice. NK depletion in BALB/c mice or defective NK function in C3H beige mice extended transgene expression compared to their appropriate controls, and attenuation of NK together with CD8 T-cell function had a synergistic effect. These findings indicate that there are intrinsic differences in the innate immune responses of different mouse strains to Ad and Ad transgenes and that NK cells, in cooperation with CD8 T cells, play a pivotal role in the early extinction of transgene expression in BALB/c mice.
Assuntos
Adenovírus Humanos/imunologia , Vírus Defeituosos/imunologia , Expressão Gênica , Vetores Genéticos/imunologia , Interferon gama/biossíntese , Interleucina-12/biossíntese , Células Matadoras Naturais/imunologia , Transgenes , Adenovírus Humanos/genética , Animais , Linfócitos T CD8-Positivos/imunologia , Linhagem Celular , Vírus Defeituosos/genética , Vetores Genéticos/genética , Humanos , Fígado/citologia , Ativação Linfocitária , Depleção Linfocítica , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BLRESUMO
This study has used the strategy of gene replacement to characterize the contribution of the adenovirus (Ad) capsid protein hexon to serotype definition. By replacing the Ad type 5 (Ad5) hexon gene with sequences from Ad2, we have changed the type specificity of the chimeric virus. The type-determining epitopes are primarily associated with loop 1 of hexon and, to a much lesser degree, with loop 2. In spite of the serotype distinctiveness of the chimeric hexon viruses, epitope similarity between the vectors resulted in a low level of cross-reactive neutralizing antibody, which in combination with activated cellular and innate arms of the immune system is sufficient to suppress gene transduction following readministration in vivo.
Assuntos
Proteínas do Capsídeo , Capsídeo/genética , Capsídeo/imunologia , Quimera/genética , Quimera/imunologia , Mastadenovirus/classificação , Mastadenovirus/genética , Infecções por Adenoviridae/imunologia , Infecções por Adenoviridae/prevenção & controle , Infecções por Adenoviridae/virologia , Animais , Anticorpos Antivirais , Antígenos Virais/genética , Linhagem Celular , Reações Cruzadas , Epitopos/genética , Genes Virais , Vetores Genéticos , Humanos , Mastadenovirus/imunologia , Testes de Neutralização , Ratos , Ratos Sprague-Dawley , Recombinação Genética , Sorotipagem , Transdução GenéticaRESUMO
We use an adenovirus vector, AdCMVmTRHR, to express thyrotropin-releasing hormone (TRH) receptors (TRH-Rs) to determine whether the size of the hormone-responsive phosphoinositide pool in mammalian cells is directly related to receptor number. Infection of HeLa cells with increasing numbers of AdCMVmTRHR caused time-dependent graded expression of TRH-Rs. Measurement of cytoplasmic free Ca2+ in individual cells permitted quantitation of the fraction of cells responsive to TRH. Infection with 100 AdCMVmTRHR particles/cell or more led to TRH responsiveness in > or = 90% of HeLa cells. Measurement of prelabeled phosphoinositides hydrolyzed during prolonged TRH stimulation assesses the size of the TRH-responsive pool. In cells infected with AdCMVmTRHR for 24 h, the size of the TRH-responsive phosphoinositide pool increased with increasing TRH-R expression. The TRH-responsive pool also increased with time after infection as the number of TRH-Rs increased. Similar observations were made in GHY and KB cells. These data confirm our previous suggestion (Cubitt, A. B., Geras-Raaka, E., and Gershengorn, M. C. (1990) Biochem. J. 271, 331-336) that there are hormone-responsive and -unresponsive pools of cellular phosphoinositides and that the maximal size of the TRH-responsive pool is directly related to the number of TRH-Rs.
Assuntos
Cálcio/metabolismo , Técnicas de Transferência de Genes , Fosfatidilinositóis/metabolismo , Receptores do Hormônio Liberador da Tireotropina/biossíntese , Receptores do Hormônio Liberador da Tireotropina/fisiologia , Hormônio Liberador de Tireotropina/farmacologia , Adenoviridae , Animais , Feminino , Expressão Gênica , Vetores Genéticos , Células HeLa , Humanos , Células KB , Cinética , Mamíferos , Fatores de Tempo , Neoplasias do Colo do ÚteroRESUMO
Sequence elements within the mouse beta maj-globin transcription unit required for efficient termination of transcription by RNA polymerase II have been delineated. To facilitate nascent-chain analysis of termination, the DNA segment in which transcription ceases was introduced into the adenovirus chromosome within its E1A transcription unit. Two beta-globin DNA elements were required to effect efficient termination: an upstream sequence that includes two poly(A) addition signals and a downstream region previously shown to be where RNA synthesis stops. The role of poly(A) addition in termination was established by introduction of several single base pair substitutions into the AATAAA polyadenylylation motifs. These mutations inhibited both polyadenylylation and termination within the beta-globin DNA segment. Therefore, poly(A) addition appears to be a prerequisite for efficient termination.
Assuntos
Genes Reguladores , Globinas/genética , Poli A/genética , RNA Polimerase II/genética , Regiões Terminadoras Genéticas , Transcrição Gênica , Animais , Análise Mutacional de DNA , Camundongos , RNA Mensageiro/genéticaRESUMO
Adenovirus-mediated gene transfer experiments have demonstrated an exceptional efficiency of virus uptake and gene expression in a variety of in vivo models. Unfortunately, the efficiency of gene delivery is not accompanied by long-term gene expression. Maximal gene expression peaks during the first week of infection followed by a rapid decline to near baseline levels within several weeks. Data from several laboratories implicate host cellular and humoral immune responses as being responsible for the limited duration of expression and for the inability to successfully readminister a gene using adenovirus vectors. In this study we have examined two strategies which, independently or in combination, circumvent aspects of the host immune response against adenovirus-mediated gene therapy. The first strategy explores induction of immune tolerance in the experimental host as a method to increase the duration of gene expression and as a method to allow readministration of adenovirus expression vectors. Our second strategy is directed at the need to readminister adenoviral vectors to immune competent adult animals. We have demonstrated that a sequential exposure of rats to at least two other adenovirus serotypes does not compromise our ability to successfully administer an Ad5-based CAT expression vector. The characterization of serotype-specific neutralizing response indicates that the construction and use of Ad expression vectors from different serotypes will facilitate a useful adenovirus-based strategy allowing multiple administrations of a target gene.
Assuntos
Adenovírus Humanos/imunologia , Terapia Genética/métodos , Vetores Genéticos/imunologia , Adenovírus Humanos/genética , Adenovírus Humanos/crescimento & desenvolvimento , Animais , Animais Recém-Nascidos , Anticorpos Antivirais/sangue , Células Cultivadas , Cloranfenicol O-Acetiltransferase/biossíntese , Cloranfenicol O-Acetiltransferase/genética , Esquema de Medicação , Fibroblastos , Expressão Gênica , Vetores Genéticos/administração & dosagem , Vetores Genéticos/genética , Tolerância Imunológica , Pulmão/citologia , Dados de Sequência Molecular , Testes de Neutralização , Ratos , Ratos Sprague-DawleyRESUMO
Biological studies of seven-transmembrane region G protein-coupled receptors have been restricted by available techniques for gene transfer into mammalian cells. We have created a highly efficient adenovirus-based expression vector for the thyrotropin-releasing hormone (TRH) receptor (TRH-R), AdCMVmTRHR, to circumvent difficulties encountered when transient or stable plasmid expression systems are used. We show that infection with AdCMVmTRHR results in fully functional TRH-Rs, which can be expressed in a broad range of mammalian cell types, including those resistant to conventional transient transfection. TRH-Rs can be expressed at high levels, up to 2 x 10(6) receptors/cell. Expression in several cell lines in culture reveals that rapid TRH-R desensitization by TRH and phorbol 12-myristate 13-acetate is cell type specific. The versatility of adenovirus-mediated gene transfer and expression of TRH-Rs not only facilitates in vitro studies of TRH-R biology but also provides a valuable in vivo expression vector capable of extending TRH-R studies to animal model systems.
Assuntos
Receptores do Hormônio Liberador da Tireotropina/metabolismo , Adenoviridae/genética , Animais , Regulação para Baixo/efeitos dos fármacos , Técnicas de Transferência de Genes , Vetores Genéticos , Técnicas In Vitro , Camundongos , Receptores do Hormônio Liberador da Tireotropina/genética , Acetato de Tetradecanoilforbol/farmacologia , Hormônio Liberador de Tireotropina/farmacologiaRESUMO
To study DNA double-strand break (DSB) repair in mammalian cells, the Saccharomyces cerevisiae HO endonuclease gene, or its recognition site, was cloned into the adenovirus E3 or E1 regions. Analysis of DNA from human A549 cells coinfected with the E3::HO gene and site viruses showed that HO endonuclease was active and that broken viral genomes were detectable 12 h postinfection, increasing with time up to approximately 30% of the available HO site genomes. Leftward fragments of approximately 30 kbp, which contain the packaging signal, but not rightward fragments of approximately 6 kbp, were incorporated into virions, suggesting that broken genomes were not held together tightly after cleavage. There was no evidence for DSB repair in E3::HO virus coinfections. In contrast, such evidence was obtained in E1::HO virus coinfections of nonpermissive cells, suggesting that adenovirus proteins expressed in the permissive E3::HO coinfection can inhibit mammalian DSB repair. To test the inhibitory role of E4 proteins, known to suppress genome concatemer formation late in infection (Weiden and Ginsberg, 1994), A549 cells were coinfected with E3::HO viruses lacking the E4 region. The results strongly suggest that the E4 protein(s) inhibits DSB repair.